ADNRX Mutual Fund (American Beacon ARK Transformational Innovation Fund Class R6) is managed by American Beacon Funds. ADNRX expense ratio is 1.05%, holding 43 positions across sectors including Information Technology, Health Care, Unknown. Inception date: 2020-10-28.

ADNRX performance shows a YTD return of -5.93%. The 1-year return is 17.01% and the 5-year return is -12.09%.

ADNRX top holdings include Tesla Inc (10.4%), Crispr Therapeutics Ag Common Stock Chf.03 (6.2%), Tempus Pe (5.1%), Shopify Inc. (4.8%), Circle Internet Group In (4.5%). View all ADNRX holdings, sector breakdown, or dividend history.

ADNRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ADNRX alternatives are available via the screener, along with tax-loss harvesting opportunities.